By integrating experiments, bioinformatics prediction and validation, 62 key targets (36 TBM’s targets and 26 known therapeutic targets of HCC) were identified after analyzing TBM-HCC interactions. The gene discussed is MUC5AC; the disease is hepatocellular carcinoma.